The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK
Open accessAbstract
Metformin (1,1-dimethylbiguanide hydrochloride) is the most commonly used drug to treat type II diabetic patients. It is believed that this drug has several other beneficial effects, such as anti-inflammatory and anticancer effects. Here, we wanted to evaluate the effect of metformin on the production of reactive oxygen species (ROS) by human macrophages. Macrophages are generated in vivo from circulating monocytes depending on the local tissue environment. In vitro proinflammatory macrophages (M1) and anti-inflammatory macrophages (M2) can be generated by culturing monocytes in the presence of different cytokines, such as GM-CSF or M-CSF, respectively. We show that metformin selectively inhibited human monocyte differentiation into proinflammatory macrophages (M1) without inhibiting their differentiation into anti-inflammatory macrophages (M2). Moreover, we demonstrate that, in response to LPS, M2 macrophages produced ROS, which could be very harmful for nearby tissues, and metformin inhibited this process. Interestingly, metformin with LPS induced activation of the adenosine-monophosphate-activated protein kinase (AMPK) and pharmacological activation of AMPK by AICAR, a known AMPK activator, decreased ROS production, whereas the deletion of AMPK in mice dramatically enhanced ROS production in different types of immune cells. These results suggest that metformin exhibits anti-inflammatory effects by inhibiting the differentiation of human monocytes into M1 macrophages and by limiting ROS production by macrophages via the activation of AMPK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, several antifibrotic interventions -including traditional Chinese medicinal (TCM) compounds and pharmaceutical agents such as metformin, glucagon-like peptide-1 receptor agonists (GLP-1RAs) or SGLT2 inhibitors (SGLT2is)- promote restorative macrophage polarization, at least in part, through activation of AMPK-dependent pathways and enhance hepatic autophagy (34, 39, 41–44).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“At a cellular level, studies showed that metformin increased AMPK activity in hepatocytes [6].”
BackgroundBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Babior, B. M., Kipnes, R. S., & Curnutte, J. T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107236 · Cited by 2,931 · cited 1×
“These macrophages have proinflammatory functions, such as phagocytosis accompanied by reactive oxygen species (ROS) production [25], cytolytic and proteolytic activities, removal of damaged tissues known as M2 macrophages.”
BackgroundFrom Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067 · cited 2×
“Several key regulatory inflammatory roles are attributed to macrophages, which are heterogeneous cells present in lymphoid and nonlymphoid tissues [22].”
Backgroundthe Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1×
“These macrophages exhibit anti-inflammatory functions, such as tissue repair and remodeling, angiogenesis, and immunosuppression [26], and show different transcriptional profiles depending on their localization [27].”
BackgroundCellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720 · cited 3×
“The transient reduction in cellular energy (a decrease in ATP levels versus an increase in AMP levels), as well as the phosphorylation of AMPK both activate switching of the cell’s status from anabolic to catabolic [1,14,15].”
BackgroundSteinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK is a phylogenetically conserved serine/threonine protein kinase [7,8].”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,253 · cited 1×
“Both the phosphorylation of AMPK and its binding with a nucleotide lead to its activation [58].”
Background
Research works printed but not linked: 1
- Katzung, B.G. (2017). Pancreatic Hormones & Antidiabetic Drugs. Basic & Clinical Pharmacology, McGraw-Hill Education.
Cited by
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Cao, G., Gong, T., Du, Y., Wang, Y., Ge, T., & Liu, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113686 · Cited by 115
The Role and Mechanism of Metformin in Inflammatory Diseases
Lin, H., Ao, H., Guo, G., & Liu, M. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s436147 · Cited by 104
“141,142 While apart from affecting macrophage polarization, metformin could play an anti-inflammatory role by inhibiting the fatty acid synthesis and Akt palmitoylation in macrophages.”
Insulin resistance induced by obesity: Mechanisms, metabolic implications and therapeutic approaches
Choo, Y. N., Ravi, R. N., & Subramaniyan, V. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11509-3 · Cited by 55
Hu, H., Zhang, W., Zhou, Y., Zhao, K., Kuang, J., Liu, X., Li, G., & Xi, Y. (2024) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-024-00989-1 · Cited by 49
Wound Healing versus Metastasis: Role of Oxidative Stress
Lopez, T. E., Wendremaire, M., Lagarde, J., Duquet, O., Alibert, L., Paquette, B., Garrido, C., & Lirussi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10112784 · Cited by 46
“Indeed, decreased M2 ROS production, after lipopolysaccharide (LPS) treatment, do not affect the expression of M2 markers such as CD163 or CD200R [53].”
Background
Metadata
- Authors
- Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Balamand (LB)
- Centre de Recherche sur l’Inflammation (CRI), Laboratoire d’Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris, INSERM-U1149, CNRS-ERL8252, 75018 Paris, France
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2022-01-29
- Volume
- 10
- Issue
- 2
- Pages
- 319
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC8869356
- OpenAlex
- W4210604230
- Cited by
- 63
- References
- 60
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 22 · 2023: 7 · 2022: 3
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0017)
- Institut National de la Santé et de la Recherche Médicale
- Agence Universitaire de la Francophonie
- Centre National de la Recherche Scientifique
- Université de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, reactive oxygen species, M2 macrophages, AMPK, monocyte differentiation, M1 macrophages, anti-inflammatory activity, lipopolysaccharide, AICAR, type 2 diabetes, biguanides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK. https://app.cochat.ai/papers/10.3390/biomedicines10020319
- The paper
- Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J. (2022). Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK. Biomedicines. https://doi.org/10.3390/biomedicines10020319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.